Market Cap
4.09B
P/E Ratio (TTM)
13.17
Free Float
-
Volume (30D Avg)
-
1Y Change
-
Shares Outstanding
12.10M
| Period | Revenue | Profit After Tax | EPS |
|---|---|---|---|
| 2025 | 3.78M | 27,677 | 2.29 |
| 2024 | 3.16M | -4,763 | -0.39 |
| 2023 | 3.04M | -7,207 | -0.6 |
| 2022 | 2.85M | 231,797 | 19.16 |
| Ex-Date | Amount | Yield (%) |
|---|---|---|
| Sep 22, 2023 | Rs. 1.50 | 1.84% |
| Oct 19, 2022 | Rs. 1.50 | 1.11% |
| Oct 18, 2021 | Rs. 1.50 | 0.57% |
| Oct 16, 2018 | Rs. 1.20 | 0.45% |
Otsuka Pakistan Limited was incorporated in Pakistan as a public limited company. The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan
30 - B, Sindhi Muslim Co-Operative, Housing Society, Karachi
M/s. Yousuf Adil Chartered Accountants
THK Associates (Private) Limited, Plot No. 32-C, Jami Commercial Street 2, D.H.A, Phase-VII, Karachi
June
Chief Executive Officer
Moin Ur Rehman
Chairperson
Mikio Bando
Company Secretary
Shahab Khalid Subzwari
